Related Experiment Video
Updated: Jul 6, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility
Richard Grieve1, Marina Grishchenko, John Cairns
1London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK. richard.grieve@lshtm.ac.uk
Abstract:
The choice of instrument (e.g. EQ-5D vs. SF-6D) can lead to different health-related utility scores, but it is unclear why these differences arise and whether they change cost utility analysis (CUA) results. This paper addresses these issues using a case study where using SF-6D rather EQ-5D led to greater utility gain and a lower cost per QALY for treatment. The paper examines reasons for this difference. This paper finds that an important factor was the inclusion in the SF-6D descriptive system of separate items for "vitality" and "social functioning", not explicitly included in EQ-5D. Further studies are required that examine the impact of the choice of instrument on cost-utility.
Related Concept Videos
Bioequivalence Data: Statistical Interpretation
Drug Dissolution: Requirements and Profile Comparison
Dose-Response Relationship: Potency and Efficacy
Expected Frequencies in Goodness-of-Fit Tests
Friedman Two-way Analysis of Variance by Ranks
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):